B Braun Medical Inc Drug Patent Portfolio
B Braun Medical Inc owns 1 orange book drug protected by 2 US patents Given below is the list of B Braun Medical Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9504666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | 11 Dec, 2033 | Active |
| US8969412 | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture | 05 Sep, 2026 | Active |
Latest Legal Activities on B Braun Medical Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of B Braun Medical Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 May, 2024 | US9504666 |
|
Correspondence Address Change
Critical
| 10 Nov, 2022 | US8969412 |
|
Correspondence Address Change
Critical
| 09 Nov, 2022 | US8969412 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 17 Aug, 2022 | US8969412 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 May, 2020 | US9504666 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Aug, 2018 | US8969412 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 29 Nov, 2016 | US9504666 |
|
Recordation of Patent Grant Mailed
Critical
| 29 Nov, 2016 | US9504666 |
|
Email Notification
Critical
| 10 Nov, 2016 | US9504666 |
|
Issue Notification Mailed
Critical
| 09 Nov, 2016 | US9504666 |
| Dispatch to FDC | 28 Oct, 2016 | US9504666 |
|
Application Is Considered Ready for Issue
Critical
| 28 Oct, 2016 | US9504666 |
|
Issue Fee Payment Verified
Critical
| 25 Oct, 2016 | US9504666 |
|
Issue Fee Payment Received
Critical
| 25 Oct, 2016 | US9504666 |
|
Electronic Review
Critical
| 29 Jul, 2016 | US9504666 |
B Braun Medical Inc's Family Patents
B Braun Medical Inc Drug List
Given below is the complete list of B Braun Medical Inc's drugs and the patents protecting them.
1. Clorotekal
Clorotekal is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9504666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
11 Dec, 2033
(8 years from now)
| Active |
| US8969412 | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture |
05 Sep, 2026
(1 year, 3 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clorotekal's drug page